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Collagen-derived proline promotes pancreatic
ductal adenocarcinoma cell survival under nutrient
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Tissue architecture contributes to pancreatic ductal adenocarcinoma (PDAC) phenotypes.
Cancer cells within PDAC form gland-like structures embedded in a collagen-rich meshwork
where nutrients and oxygen are scarce. Altered metabolism is needed for tumour cells to
survive in this environment, but the metabolic modifications that allow PDAC cells to endure
these conditions are incompletely understood. Here we demonstrate that collagen serves as a
proline reservoir for PDAC cells to use as a nutrient source when other fuels are limited. We
show PDAC cells are able to take up collagen fragments, which can promote PDAC cell
survival under nutrient limited conditions, and that collagen-derived proline contributes to
PDAC cell metabolism. Finally, we show that proline oxidase (PRODH1) is required for PDAC
cell proliferation in vitro and in vivo. Collectively, our results indicate that PDAC extracellular
matrix represents a nutrient reservoir for tumour cells highlighting the metabolic flexibility of
this cancer.
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P
ancreatic ductal adenocarcinoma (PDAC) has among the
highest mortality rates across all forms of cancer1,2 and
most patients survive o2 years post diagnosis3. The most
common driver mutations in PDAC are activating mutations in
K-RAS, observed in 95% of cases4, followed by loss of several
tumour-suppressor genes (INK4A and ARF, TP53, SMAD4)5,6.
PDAC tumours have a characteristic tissue architecture with
cancer cells organized to form glandular structures surrounded by
a tight desmoplasia composed of activated fibroblasts, immune
cells, neurons and a dense collagen meshwork7,8. This fibrosis
impedes vascularization, limits chemotherapy delivery9,10 and
results in regions of reduced oxygen and nutrient delivery to the
tumour cells11.
Mutant K-RAS promotes glucose metabolism to provide PDAC
cells with ATP, reducing power (NADPH) and nucleoside
precursors12. In addition, oncogenic K-RAS promotes enhanced
glutamine catabolism to maintain redox status13, as well as
extracellular protein uptake through macropinocytosis14. Yet
because these tumours have poor nutrient delivery, the source(s)
of nutrients for cancer cells in pancreatic tumours in vivo remains
an open question. Given that pancreatic tumours contain a
collagen-rich network that surrounds the cancer cells15,16, we
hypothesized that collagen itself might represent an important
nutrient source for tumour cells.
Collagen proteins are primarily synthesized by fibroblasts17
and remodelling normally occurs through breakdown into
fragments by either extracellular or membrane-bound proteases
present in the PDAC micro-environment including cathepsins
and matrix metalloproteases18–20. Collagen fragments can induce
downstream signalling in cells or be endocytosed21,22. Within
fibroblasts, endocytosed collagen fragments are degraded by
intracellular proteases into single amino acids, including proline,
which is 25% of the total amino acid composition of collagen.
In colorectal cancer, proline catabolism mediated by proline
oxidase (POX, also called PRODH1) promotes tumour cell
survival through either ATP production or autophagy induction,
depending on whether the cancer cells are confronted with
nutrient or hypoxic stress, respectively23. However, direct
evidence of collagen uptake and degradation by pancreatic
cancer cells is lacking, and whether proline from collagen
breakdown is used to promote PDAC tumour cell survival or
proliferation under nutrient stress is not known.
To test this possibility we used both human PDAC samples
and the Pdx1-Cre;KrasG12D;Ink4a / (PKI) PDAC mouse
model24, and demonstrate that PDAC cells catabolize collagen
from their environment when nutrients in vitro are limited. We
also show that collagen-derived proline is metabolized to fuel the
tricarboxylic acid (TCA) cycle and contributes to PDAC cell
survival under restrictive nutrient conditions, and that PRODH1
expression is important for PDAC tumour growth.
Results
PDAC tumours have an extracellular matrix rich in collagens.
We first confirmed the high collagen content of human and
mouse PDAC tumours. Masson’s trichrome stained approxi-
mately 41% of the tumour area in human sections and 36% of
PKI tumours (Fig. 1a). We then performed immunohistochemical
(IHC) staining for collagens I and IV, the main collagen proteins
found in human PDAC15,25,26. Antibodies against collagens I and
IV each stained a large proportion of the tumour sections from
both humans and mice (Fig. 1b). We also examined expression
of collagen I- and IV-specific metalloproteases, namely matrix
metalloprotease 13, 2 and 9, along with prolidase (encoded by
Pepd), a protease specific for X-proline dipeptides (with X
representing glycine or lysine) and found increased expression
of these proteases in PDAC compared to control pancreas
(Fig. 1c). While prolidase is described as an intracellular
enzyme27, IHC staining using an antibody to prolidase
overlapped with extracellular matrix (ECM) in both human
PDAC and PKI tumours (Fig. 1d) and we also found that
prolidase was excreted into the media from PDAC cells grown in
culture (Fig. 1e). Together, these data confirm that PDAC
tumours are enriched in collagen and suggest that enzymes are
present in the tumour micro-environment that can generate
collagen fragments and free amino acids that might be used as a
fuel source by cancer cells.
PDAC cells express proline metabolic enzymes. To begin to test
the hypothesis that PDAC cells metabolize proline-derived from
collagen breakdown, we measured expression of enzymes
involved in metabolism of both free proline and proline in
collagen (Fig. 2a)28. As assessed by IHC, PRODH1 and P4HA3
(the enzymatic subunit of P4H involved in proline hydroxylation
in collagen synthesis) were found in tumour gland-like structures
and we confirmed epithelial localization by co-staining with
wide-spectrum cytokeratin (wsKRT) in murine tumour sections
(Fig. 2b,c). Interestingly, we also noted cells disseminated in the
stroma that are PRODH1 or P4HA3 positive (Fig. 2c). We then
assessed overall tumour expression of PRODH1 and P4HA3 via
immunoblot and found that PRODH1 is over-expressed
(sevenfold) in PDAC relative to control tissue while P4HA3
protein levels are unchanged (Fig. 2d). Finally, we confirmed
increased PRODH1 expression in human PDAC relative to
normal pancreas via IHC (Fig. 2e) as well as expression in
epithelial cells in all human pancreatic tumours examined
(Supplementary Fig. 1). These data indicate enzymes involved
in proline metabolism are expressed in PDAC cells.
Nutrient-deprived PDAC cells take up collagens. Since the
dense stromal reaction impedes nutrient delivery to tumour cells,
we reasoned that pancreatic cancer cells might express matrix
remodelling and proline catabolic enzymes to allow for the
utilization of ECM proteins as a source of amino acids
under nutrient-deprived conditions. K-RAS mutant tumour
cells starved of essential amino acids are known to activate
macropinocytosis29, a phenomenon that involves the nonspecific
uptake of extracellular material into vesicles that fuse with
lysosomes, allowing subsequent metabolism of the internalized
products30. To confirm that this process is active in PK4A
cells, we utilized DQ-fluorescein-conjugated collagen I or IV
(collagen I or IV DQ). Because the fluorophore in these molecules
is quenched within the intact protein, fluorescence is only
observed following protein breakdown and allows for the
assessment of both protein uptake and cleavage31. Collagens I
and IV uptake were readily observed under both normoxic
and hypoxic culture conditions (Fig. 3a–f and Supplementary
Fig. 2a–d). In particular, uptake of collagens I and IV were
both dramatically increased in normoxia upon deprivation of
either glucose or glutamine; however, this increase was not
observed to the same extent in hypoxic cells (Fig. 3a–d and
Supplementary Fig. 2a–d). Interestingly, the macropinocytosis
inhibitor 5-N-ethyl-isopropyl-amiloride (EIPA)14 blunted the
increase in collagens I and IV DQ fluorescence observed
following glucose limitation, but resulted in increased uptake in
complete media and had no effect under glutamine-limited
conditions (Fig. 3a–d). Culturing PDAC cells under hypoxic
conditions did not enhance collagen uptake compared to
culture in normoxia with or without nutrient deprivation
(Fig. 3e,f). Moreover, hypoxia blunts the effect of EIPA
when glucose is low (Supplementary Fig. 2a,d). Taken together,
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these data demonstrate that glucose or glutamine deprivation
promotes uptake and breakdown of collagens I and IV protein by
PDAC cells, with macropinocytosis playing a key role under basal
and glucose-limited conditions while other mechanisms are likely
involved in collagen breakdown in PDAC tumours under
glutamine-limited conditions.
After collagen is taken up from the surrounding milieu, further
metabolism is necessary to breakdown the proteins and utilize
the component amino acids. To ascertain the subcellular location
of collagen in nutrient-deprived PK4A cells, we performed
co-immunofluorescence (IF) with the lysosomal membrane
protein marker LAMP1 and we demonstrated collagen localiza-
tion to punctate LAMP1-positive structures in glucose-starved
cells, consistent with some collagen IV DQ degradation within
lysosomes (Fig. 3g). EIPA-induced collagen spreading throughout
the cytoplasm was also observed, implying extra-lysosomal
degradation of collagen may also be active (Fig. 3g, EIPA).
Consistent with our above findings, collagen localization within
lysosomal vesicles was not affected by EIPA under glutamine
starvation (Fig. 3h) and no differences were observed between
normoxic and hypoxic conditions (Supplementary Fig. 2e,f).
Thus, under nutrient limited conditions PK4A cells increase
collagen uptake, but through both macropinocytosis-dependent
and independent mechanisms. Macropinocytosis appears to be a
route of collagen uptake following glucose starvation under
normoxia, while macropinocytosis-independent pathways appear
to allow collagen uptake by these cells following glutamine
starvation or in hypoxia.
One mechanism for collagen uptake other than macropinocy-
tosis is endocytosis mediated by the collagen receptor uPARAP/
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Figure 1 | Collagen types I and IV and their associated collagenases are abundant in the stromal compartment of PDAC. (a) Collagen by Masson’s
trichrome staining and (b) immunohistochemistry (IHC) of collagen proteins type I and IV in human and mouse tumour sections. Representative images
and their relative insets from n¼4 patients and n¼ 3 Pdx1-Cre;KrasG12D;Ink4a / (PKI) mice are illustrated. The percentage of total collagen
and collagen types I and IV staining intensity calculated relative to total tumour area, expressed as mean±s.e.m., is indicated. Scale bar, 100 mm.
(c) mRNA levels of the collagen specific MMP 13, 9 and 2 and prolidase (Pepd gene) measured by quantitative RT–PCR in PDAC from PKI mice (n¼ 3)
versus control pancreases from KrasG12D;Ink4a / (KI) mice (n¼ 3). Data are mean±s.e.m. *Po0.05, **Po0.01, ***Po0.001; two-tailed unpaired
Student’s t-test. (d) Prolidase localization in human and PKI mice tumours revealed by IHC (left) or immunofluorescence (IF, right), respectively.
Representative images from n¼4 patients and from n¼ 3 PKI mice. Scale bar, 100mm. (e) Prolidase levels in supernatant from PK4A cells cultured during
24 or 48 h with coated collagen I in complete media. Total loaded protein was determined by Ponceau red staining (Std: standard). Marker sizes are
indicated in kDa. Photos are representative of n¼ 3 independent experiments. Uncropped images of blots are shown in Supplementary Fig. 10. MMP, matrix
metalloproteases; RT–PCR, PCR with reverse transcription.
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Endo180. This process is found in tissues with enhanced matrix
remodelling, including many tumours32. We found that
uPARAP/Endo180 is highly expressed in PDAC compared to
control pancreases in mice (Supplementary Fig. 3a,b) and
localized to gland-like structures in both mouse and human
PDAC samples (Supplementary Fig. 3c). Thus, in addition to
macropinocytosis as a mechanism for collagen uptake, uPARAP/
Endo180 could support collagen uptake as well. Interestingly, this
receptor has been previously associated with migratory processes
in pancreatic tumours suggesting it plays an active role in
remodelling the ECM in pancreatic cancer33.
Collagen and proline promote cell survival and proliferation.
On the basis of our previous observations surrounding the active
uptake and breakdown of collagen proteins, we hypothesized
that this could support tumour cell survival in response to
nutrient deprivation, a condition thought to be present in the
pancreatic tumour micro-environment. To test this possibility, we
cultured PK4A cells for 72 h without glucose with or without
collagen supplementation, before re-introduction of complete
media for 24 h and assessment of cell survival and found
that both soluble or coated collagen significantly increased
pancreatic cell survival (Fig. 4a upper panel: two-tailed unpaired
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Figure 2 | PDAC expresses proline metabolic enzymes. (a) Free proline is metabolized in the mitochondrial matrix, first by proline oxidase (PRODH1), to
generate 1-pyrroline-5-carboxylic acid (P5C) before conversion into glutamic-g-semialdehyde (GSA). P5C dehydrogenase (P5CDH) metabolizes GSA into
glutamate and NADH. Free proline is synthesized from P5C via pyrroline carboxylases 1 and 2 (PYCR1, 2) in the mitochondrion and PYCR3 in the cytosol.
Proline incorporated into collagen (proline-Col) can be modified into hydroxyproline (OH-proline) by prolyl-4-Hydroxylases (P4H). (b,c) Localization of
PRODH1 and P4HA3 in human and PKI mice PDAC by IHC (b) and in epithelial compartment by IF co-staining with the wide-spectrum cytokeratin
(Ws KRT) epithelial marker in PKI mice (c). Representative images from n¼4 patients (b) and n¼ 3 PKI mice (b,c). Tumour glands and disseminated
cells are indicated by asterisks and arrows, respectively. Scale bar, 100mm. (d) Quantification of PRODH1 and P4HA3 protein levels in PKI mouse
PDAC and in KI mouse control pancreas revealed by western blot analysis (upper panel, with marker size indicated in kDa). Protein levels in each tissue
samples (histograms, lower panel, from n¼ 3 control KI mice and n¼ 3 PDAC PKI mice) are normalized to total loaded-proteins (Amido black staining).
Data expressed as mean±s.e.m. (***Po0.001; two-tailed unpaired Student’s t-test). Uncropped images of blots are shown in Supplementary Fig. 10.
(e) Quantification of PRODH1 protein levels in normal human pancreas (n¼ 11) and human PDAC samples (n¼ 10). PRODH1 levels are normalized to one
normal pancreas used as a reference. Data are illustrated as mean±95% CI, *** Po0.001; Mann–Whitney test. Images of human PDAC and normal
pancreas macroarray are displayed in Supplementary Fig. 1. CI, confidence interval.
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Student’s t-test, P¼ 0.0075, Supplementary Fig. 4a,b). EIPA
reduced cell survival, further suggesting that macropinocytosis of
collagen (along with other nutrients) is involved in cell survival
rescue under glucose-limited conditions (Fig. 4a). Interestingly,
over the 3 days of glucose starvation, glutamine concentration
decreases to low levels creating a concomitant glucose and
glutamine deprivation at 72 h of culture (Fig. 4a lower panel).
Looking downstream of oncogenic K-RAS, we found that under
glucose and glutamine-depleted conditions, ERK1/2 phosphoryla-
tion is increased in the presence of collagen (Fig. 4b, upper gels). In
K-RAS mutant cells, essential amino-acid deprivation strongly
represses the mTORC1 pathway, but the uptake of extracellular
proteins can reactivate signalling and result in phosphorylation of
downstream targets such as S6K1 (ref. 29). However, collagen
addition in glucose-free or glutamine-reduced conditions does not
appear to impact downstream mTORC1-signalling compared to
basal levels observed without collagen (Fig. 4b, lower gels). Thus,
collagen both rescues pancreatic tumour cell survival and increases
ERK1/2-pathway activation following glucose and/or glutamine
shortage without engaging the mTORC1-signalling cascade.
As the proline catabolic enzyme PRODH1 is over-expressed in
PDAC compared to control pancreas tissue (Fig. 2) and collagen
breakdown can be a source of proline (Fig. 3), we investigated if
PK4A cells could use collagen-derived proline to maintain their
survival and/or proliferation under nutrient limitation. We first
confirmed that the extracellular secretion of prolidase we
previously observed in murine and human tumours (Fig. 1d,e)
was also present under low glucose and glutamine conditions
(Fig. 4c). This suggests external degradation of collagen might be
used as a source of free proline in case of nutrient deprivation.
To assess the possible fates of this free proline and gain initial
insight into how it might promote survival and/or proliferation in
some conditions, we utilized [U-14C]-proline to trace the fate of
proline into all major biomass and metabolite compartments of
PDAC cells34. Interestingly, we found that proline carbon
primarily contributes to biomass through incorporation into
protein, although a small contribution of proline carbon to other
macromolecules was also observed (Supplementary Fig. 5).
Although relatively small, the presence of proline-derived
carbon in non-protein metabolic compartments as well as the
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(h) media under normoxic conditions with or without EIPA. Insets show magnification of Col IV, Lamp1 or Col IV/Lamp1 (merge) PKA4 cells in each
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increased expression of PRODH1 in PDAC (Fig. 2d) led us to
more closely examine proline metabolism under nutrient limited
conditions. We cultured PK4A cells in either complete media, low
glucose (0, 1, 5mM) or low glutamine (0, 0.5mM) conditions,
with or without free proline, in the presence or absence of
deshydroproline (DHP), a competitive inhibitor of PRODH1.
Exposure to DHP diminishes both cell survival and proliferation
under some nutrient limited conditions (5, 1mM glucose and
0.5mM glutamine), whereas addition of excess free proline
rescued the survival and proliferation of the DHP-treated cells
(Fig. 4d upper panel, Fig. 4e). In hypoxic conditions, inhibition of
PRODH1 does not impact cell survival to the same extent as it
does under normoxia (Fig. 4d lower panel). Taken together, these
data argue that proline catabolism through PRODH1 can support
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cell survival and proliferation especially in glucose and glutamine-
restricted conditions.
Proline degradation under low glutamine limits glycolysis.
Glutamate serves as the common metabolic intermediate between
glutamine and proline metabolism35. We confirmed PDAC cells
in vitro actively deplete glutamine from the culture media
(Fig. 5a). However, as has been demonstrated in other contexts36,
cells cultured in low glutamine (0.5, 0mM) consume less glucose
than cells cultured in high glutamine medium (4mM) and also
show decreased lactate production (Fig. 5b). Because lactate is
derived exclusively from glucose (Fig. 5c and Supplementary
Fig. 6a,b), this decrease in lactate suggested that restricting
glutamine availability can decrease glycolytic flux.
We next evaluated how proline catabolism influenced the
metabolic status of glutamine-restricted PDAC cells. Interest-
ingly, blocking proline catabolism with PRODH1 inhibition
significantly increased glycolytic activity of PK4A cells cultured
under low glutamine conditions, as shown by an increased
glucose consumption and lactate production after DHP treatment
(Fig. 5d: two-tailed unpaired Student’s t-test, P¼ 0.0481 and
Po0.0001, respectively). This increase in glucose consumption
and lactate production in response to DHP was inhibited when
free proline was added back to glutamine-low culture media,
supporting the notion that proline degradation may serve as an
alternative nutrient source to glucose when glutamine is limiting.
Proline fuels tricarboxylic acid (TCA) cycle metabolism. To
confirm that proline catabolism is active and to begin to address
the fate of catabolized proline in PDAC cells we performed a
series of tracing experiments utilizing U-13C-proline. We first
generated U-13C-proline-containing ECM using primary mouse
embryonic fibroblasts (MEFs) (Fig. 6a,b and Supplementary
Fig. 7a,b) to assess whether ECM protein-derived proline could be
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harvested by PDAC cells under nutrient limited conditions.
Assessment of the amino acid composition demonstrates that the
proportion of individual amino acids in ECM differs from that
found in Dulbecco’s modified Eagle’s medium (DMEM), and that
ECM contains relatively larger quantities of proline and glycine
(Supplementary Fig. 7c). After plating cells on this labelled
matrix, we switched to media with limited glucose and glutamine
concentrations for 24 h (Fig. 6a). We observed accumulation of
free U-13C-proline from the labelled ECM into PDAC cells
when nutrients were deprived (Fig. 6c), confirming that
PK4A cells are able to extract proline from ECM. To address
the fate of catabolized free proline under the same nutrient-
deprived conditions, we traced U-13C-proline in these cells.
Consistent with the ability of proline to rescue cell viability and
proliferation under nutrient limitation, label from proline
was found in all TCA cycle intermediates in PDAC cells, with
labelling patterns indicating multiple turns of the TCA cycle,
under conditions where glucose or glutamine were limited
(Fig. 6d and Supplementary Fig. 7d). These contributions
are slightly decreased under hypoxia but under glutamine-free
conditions we observe increased Mþ 5 labelling of citrate, raising
the possibility that proline can substitute as a substrate for
reductive a-ketoglutarate metabolism, as it was previously
described for glutamine in hypoxic or anchorage independent
culture conditions37,38 (Fig. 6e and Supplementary Fig. 8a).
Furthermore, we observe inhibition of proline metabolism
to glutamate by 1mM DHP in the presence of 500mM
U-13C-proline under both 0.5mM glutamine (with 25mM
glucose) and 5mM glucose (with 4mM glutamine) conditions
(Fig. 7a and Supplementary Fig. 8b). Under these conditions DHP
also decreases oxygen consumption in cells treated with
oligomycin and carbonyl cyanide-4-(trifluoromethoxy) phenyl-
hydrazone (FCCP) (the combination of which enables the full
oxygen respiratory capacity of cells), while addition of excess
proline restores full respiration capacity (Fig. 7b). Taken together,
these data suggest collagen-derived proline promotes cell survival
and can contribute to proliferation under nutrient limitation at
least in part by supporting TCA cycle metabolism and cellular
respiration.
PRODH1-mediated proline metabolism promotes PDAC growth.
We finally evaluated the requirement for PRODH1-mediated
proline catabolism on pancreatic tumour cell phenotypes
in vitro and in vivo. We generated two PK4A cell lines with
CRISPR-Cas9-mediated disruption of the PRODH1 gene,
in which the PRODH1 protein was decreased up to 80%
(Sg-PRODH1_clone9 and Sg-PRODH1_clone3) as compared to
sg-Control_PK4A cells (sg-Control) (Supplementary Fig. 9a). We
cultured these cell lines at low confluence under complete media
or glucose-restricted conditions and found that disruption of
PRODH1 not only drastically limited the clonogenic capacity of
PK4A cells in full, but also in low glucose conditions (Fig. 8a and
Supplementary Fig. 9b). We then tested the ability of Sg-Control
PK4A cells and Sg-PRODH1 PK4a cells to form tumours in nude
mice. Strikingly, the tumorigenic potential of PK4A cells was
dramatically impaired when PRODH1 was inhibited (Fig. 8b) and
Ki-67 staining was lower in tumours with disrupted PRODH1
expression compared to control tumours (Fig. 8c). Taken
together, these data indicate that PRODH1 expression promotes
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pancreatic tumour growth, and argues that acquisition of proline
from the metabolism of collagen in the tumour environment
promotes PDAC tumour cell survival.
Discussion
The metabolic flexibility of tumour cells is widely recognized39;
however, the tissue context can greatly constrain which nutrients
and pathways are utilized by cancer cells40–43. PDAC tumours
cells are embedded within a tight collagen-rich desmoplasia,
lowering vascularization, nutrients and oxygen supply to tumour
cells and severely restricting the pool of available substrates to
support survival or even growth. However, the collagen matrix
provides a potential source of some amino acids, including
proline and we find that tumour cells take up and degrade ECM
proteins including collagens I and IV to support TCA cycle
metabolism under nutrient limited conditions (Fig. 8d). This use
of ECM proteins illustrates how cancer cell can exploit their
immediate environment and utilize available substrates when
other fuels are limiting.
Recent work has highlighted the importance of the bulk uptake
of soluble protein via mutant K-RAS-driven macropinocytosis as
a source of amino acids to support survival and proliferation
under times of nutrient stress in vitro14,29,44. Consistent with
these results, we found macropinocytosis was major contributor
to the uptake of collagens I and IV proteins, presumably along
with other nutrients, at least under conditions of glucose
deprivation. Interestingly, however, this process did not seem to
play a role under hypoxia or glutamine-restricted condition.
This raises the possibility that parallel mechanisms of collagen
uptake involved in cancer progression45, including the similarly
upregulated uPARAP/Endo180 pathway, actively participate in
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metabolism by internalizing intact or partially degraded collagen
fragments22,46. In addition, we demonstrate that collagen uptake
promotes PK4A cell survival under nutrient deprivation and leads
to the activation of the ERK1/2-pathway (Fig. 4). A signalling
connection between collagen and ERK activation was previously
identified, although mainly associated with cancer cell migration
and invasion47,48. Thus our data now provide an additional layer
of the interplay between collagen, ERK signalling and cell
survival. The absence of mTORC1 activation by collagen
degradation underscores the mechanisms exploited by PDAC
cells to favour the active uptake and use of ECM proteins. More
specifically, mTORC1 signalling has been shown in vitro to block
utilization of exogenous protein-derived amino acids and
inhibition of this complex promotes continued division under
nutrient limited conditions in vivo29.
Our work shows that PDAC cells use proline under
nutrient deprivation to sustain viability via TCA cycle metabolism
(Fig. 6). Previous studies showed that glutamine feeds the
TCA cycle to produce proline and that PRODH1 activity
promotes colon tumour cell survival under nutrient stress via
autophagy and/or ATP production35,49. In PDAC, we also find
that proline degradation can fuel glutamine synthesis primarily in
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glutamine-free conditions. More broadly, however, increased
proline degradation and entry into the TCA cycle for oxidation
occurs in the nutrient limited condition examined here. Thus,
proline appears to be able to substitute at least temporarily for
glucose and glutamine to promote PDAC cell survival under
extremes of nutrient limitation, likely by generating ATP. Hence,
we propose that, as the main reservoir of proline in PDAC,
collagen represents an important nutrient pool for pancreatic
tumours, although it is important to recognize that insoluble
ECM proteins do not necessarily reflect a well-balanced diet
of essential amino acids (Supplementary Fig. 7c) to promote
long-term proliferation in all PDAC cells. Nevertheless,
the metabolism of ECM-derived proline to replenish TCA
intermediates may be a critical mechanism to promote the
survival of the frequently chemo-resistant and slow-dividing cells
nearest to tumour cores. Furthermore, some degree of proline
metabolism through PRODH1 appears necessary for proliferation
under even nutrient replete conditions and enables PDAC
tumour growth in vivo in addition to the aforementioned
survival benefit. This raises the possibility then that targeting
proline metabolism specifically through the inhibition of catabolic
enzymes such as PRODH1, might both slow overall tumour
growth and compromise the survival of more resilient cancer cells
within the tumour.
Methods
Human samples. Formalin-fixed, paraffin-embedded tissue samples of PDAC
were obtained from 18 patients who had undergone surgery at the Department of
Digestive Surgery, North Hospital, Public Assistance of Marseille’s Hospitals,
France. Before surgery, all patients had signed an informed consent form that had
been approved by the local ethics committee (Agreement reference of CRO2 tissue
collection: DC-2013-1857). Histological examination confirmed a diagnosis of
PDAC in all cases. Tumour staging was performed according to the International
Union Against Cancer TNM System (6th edition).
Mouse strains and tissue collection. Male Pdx1-Cre;LSL-KrasG12D;Ink4a/Arffl/fl
(PKI) PDAC-bearing mice, and male LSL-KrasG12D;Ink4a/Arffl/fl(KI) control
littermates were obtained as previously described50. After mice were killed at
the age of 9 weeks, pieces of tumour or control pancreas were either fixed in
4% (wt/vol) formaldehyde, snap-frozen in cold isopentane for further analysis, or
directly homogenized in 4M guanidinium isothiocyanate lysis buffer for efficient
pancreatic RNA extraction, according to previously published protocols51.
All animal care and experimental procedures were performed in agreement with
the Animal Ethics Committee of Marseille under reference 01527.02.
Cell culture conditions. PK4A cell line was isolated from PKI murine PDAC.
Briefly, PDAC from PKI mice were chopped into small pieces with a razor blade.
Cell homogenate was successively incubated in Hanks’ balanced salt solution (HBSS)
solutions containing 0.9 g of glucose with collagenase (30min at 37 C) and then
trypsin (5min at 37 C). Then, cells were plated and maintained in Glutamax 25mM
glucose DMEM supplemented with 10% (vol/vol) fetal bovine serum (FBS) (Gold,
GE Healthcare), 1% antibiotic/antimycotic (anti/anti) solution for several passages
before examination for epithelial markers50. PK4A cells were used from passages 18
to 28 and were demonstrated to be negative for mycoplasma contamination. For
experiments, glucose and glutamine concentrations in the base DMEM media (using
commercial L-glutamine, DMEM without glutamine, 25mM glucose or DMEM
without glucose, 4mM glutamine) were modified to the indicated concentrations
and the media was supplemented with 10% dialysed FBS (SH30079, Hyclone), and
complete media (25mM glucose, 4mM glutamine DMEM) was supplemented with
10% filtered FBS (SH30070, Hyclone), all media supplemented with 1% anti/anti.
Cells were cultured at 37 C at 21% oxygen in a 5% CO2 incubator. For hypoxic
experiments, cells were placed in a Whitley Hypoxic WorkStation (Don Whitley
Scientific) at 1% oxygen concentration, 5% CO2, 37 C. Unless otherwise stated, all
cell culture reagents were purchased from Life Technologies.
Collagen solubilization. Collagen type IV from Engelbreth–Holm–Swarm murine
sarcoma basement membrane (Sigma-Aldrich, #C0543) was solubilized in sterile
water through heating/cooling cycles. Briefly, lyophilized collagen was resuspended
in water and heated 2 h at 60 C. Dissolved material was then cooled down at
4 C O/N, re-heated 1hr at 60 C (which separates, but does not fragment
collagen fibrils) before complete resuspension and subsequent use.
Reverse transcription and quantitative real-time PCR. RNA quality was assessed
with the RNA Nano Chip kit (Agilent) on an Agilent Bioanalyser and treatment with
DNase was performed using the RNase-free DNase set (Qiagen). Five microgram of
total RNA from each sample was used to synthesize cDNA with the PrimeScript RT
reagent kit (Promega) and provided oligo-dT primers, according to the manu-
facturer’s instructions. Quantitative PCR reactions were performed with specific
primers listed in Supplementary Table 1 and the GoTaq qPCR master mix kit
(Promega) using the Mx3005P Stratagene system. Differential expressions of tran-
scripts of interest were calculated in relation to the 36B4 housekeeping transcript.
Protein extracts and western blots. Samples from PDAC and control pancreases
from PKI and KI mice were lysed (10% N-Deoxycholate, 0.1% SDS, 1% Triton
X-100, 10mM Tris pH 8, 140mM NaCl, phosphatases/proteases inhibitors (Cocktail
from Sigma-Aldrich), 1% phenylmethylsulfonyl fluoride, 1mM Sodium fluoride
(NaF), 100mM Sodium orthovadanate (Na3VO4), 40mM beta glycerophosphate),
before centrifugation (14,000 r.p.m., 10min, 4 C). Supernatants were collected and
protein concentration evaluated using BioRad Protein assay. For soluble collagen-
induced signalling studies, 5 105 PK4A cells were seeded on 6 cm plates and
cultured 72h in reconstituted, no glucose or 0.5mM glutamine DMEM with or
without water-dissolved collagen IV (20mgml 1) before protein extract preparation.
To evaluate PRODH1 levels in sg-PRODH1_ PK4A clones, 5 105 cells were seeded
on 6 cm plates 24 h before protein extract preparation. Whole cell protein extracts
(75-100mg per lane) were resolved by SDS–polyacrylamide gel electrophoresis
(SDS–PAGE) using a 10% (vol/vol) acrylamide gel and transferred onto 0.2mm
nitrocellulose membranes (GE Healthcare). After a blocking step (5% (wt/vol) non-
fat milk in TBS), primary antibodies were incubated O/N at 4 C (in non-fat milk,
5% in TBS 0.1% Tween). Following primary antibodies were used: PRODH1 (1:500,
Sigma-Aldrich, #SAB2501795), P4HA3 (1:500, Abcam, #ab101657), pERK1/2 (1:500,
Sigma-Aldrich, #M8159), ERK1/2 (1:2,000, Sigma-Aldrich, #M5670), prolidase
(1:750, Novus biological, #H00005184-M01), pT389-p70S6Kinase (1:400, Cell Sig-
naling, ##9234), p70S6Kinase (1:200, Santa Cruz Biotechnologies, #sc-8418),
uPARAP/Endo180 (1:700, Abcam, #ab70132) and b-actin (1:10,000, Sigma-Aldrich,
A5316). For western blot of decellularized ECM, ECM extracts were resolved by
SDS–PAGE using a 6% (vol/vol) acrylamide gel. An amount of 30ml of decellularized
ECM taken up in 3 SDS loading dye (200 ul per well on six-well dish) was loaded
and compared with 20mg of lysate from control MEFs. After transfer to PVDF
membrane and blocking in 5% BSA in TBSþ 0.1% Tween, blotting was performed
using primary antibodies against Collagen I (1:1,000, Millipore, #AB765P), Fibro-
nectin (1:10,000, a gift from Richard O. Hynes, Koch Institute for Integrative Cancer
Research and Howard Hughes Medical Institute, Massachusetts Institute of Tech-
nology, Cambridge, Massachusetts, USA. Antibody was used as described before52)
and Hsp90 (1:1,000, Cell Signaling, #4877). For excreted prolidase analysis, 6-well
plates were coated with 20mg/cm2 collagen I. Briefly, collagen I (0.1% in 1N acetic
acid, Sigma #C8919) was diluted 10 times in PBS, and distributed in six-well plates.
Collagen was fibrillated 2 h at 37 C. After complete evaporation, wells were washed
in PBS and dried O/N before use. 5 105 PK4A cells were seeded on collagen coated
plates for 24 to 48h in complete, no glucose or no glutamine medium. Medium was
collected at each time point, centrifuged (2,000 r.p.m., 3min) and supernatant snap-
frozen in liquid nitrogen. Before SDS–PAGE analysis, proteins were concentrated
and precipitated in 25% Trichloroacetic acid (TCA). Pellets were washed once in
10% TCA and three times in deionized water. Proteins were resuspended in lysis
buffer as stated above whilst heating pellet at 80 C until complete resuspension. An
amount of 80mg of protein were resolved onto 10% acrylamide gels. ECL protein
detection (Millipore) was performed with a Fusion Fx7 chemiluminescent imager
and the quantifications of the amounts of proteins of interest were determined by
densitometry using Image J software (NIH) and normalized to respective non-
phosphorylated proteins or to total protein stained with Amido black/Ponceau Red.
Immunohistochemistry. Formalin-fixed, paraffin-embedded, 5-mm-thick human
or mouse PDAC sections were deparaffinized in xylene and rehydrated through a
series of graded ethanol concentrations. Antigen retrieval was performed in citrate
buffer pH6 (Diapath)/Tween 0.05% or target retrieval solution at pH 6 or 9 (Dako),
before quenching endogenous peroxidase activity (3% (vol/vol) H2O2). Tissue
sections were then incubated with the following primary antibodies: P4HA3 (1:100,
Abcam, #ab101657), Prolidase (1:50, Novus biological, #H00005184-M01),
PRODH1 (1:100, Sigma-Aldrich, #SAB2501795), Collagen Ia1 (1:100, Abcam,
#ab34710), Collagen IV (1:200, Abcam, #ab6586), uPARAP/Endo180 (1:100,
Abcam, #ab70132), or Ki67 (1:100, BioLegend, 652402). Immunoreactivity was
visualized using the Vectastain ABC kit (PK-4001, Vector Laboratories) or with
biotinylated goat anti-rabbit antibody and peroxydase-conjugated streptavidin
from Dako (France). Peroxydase activity was revealed using liquid DABþ substrate
chromogen system (Dako). Counter-staining in Mayer’s Haematoxilin was
followed by a bluing step in sodium bicarbonate buffer (0.1% in water) before final
dehydration and mounting of the sections. For collagen staining, Masson’s
trichrome coloration was performed using an Artisan Link Special Staining
System (Dako), according to manufacturer’s instructions. Positive PRODH1
areas into PDAC and normal pancreases from patients were determined from
 20 magnification images using Image J software (NIH). Quantitation of collagen
staining was performed using ImageJ software (NIH).
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Immunofluorescence. Paraffin-embedded mice PDAC sections (5 mm) were
treated as for IHC before blocking in PBS/3% BSA (GE Healthcare). Tissue sections
were then incubated with primary antibodies, followed by incubation with Alexa
fluor 568- or Alexa fluor 488-conjugated secondary antibodies (1:500, Molecular
Probes). Primary antibodies were: wide-spectrum cytokeratin (1:50, wsKRT,
Acris Antibodies #BP5069) or the same ones used for IHC (P4HA3, PRODH1,
prolidase). Stained tissue sections were mounted using Prolong Gold Antifade
reagent with DAPI (Life Technologies). For immuno-cytofluorescence, 1.5 105
PK4A cells were seeded on 60-mm-thick glass coverslips in complete medium.
Twenty-four hours later plates were washed in PBS, and experimental media
added, supplemented with DQ-Fluorescein-conjugated collagen IV (20 mgml 1,
Life technologies) with or without EIPA (5-N-ethyl N-isopropyl amiloride (EIPA),
30mM in DMSO), either under normoxia (21% oxygen) or hypoxia (1% oxygen).
Cysteine protease inhibitor E64 (20mM in water) was added to each condition to
slow collagen lysosomal degradation, thus promotes its accumulation and
visualization as described53. The day of the experiment, cells were washed in PBS,
and fixed in cold acetone. For LAMP1 staining the primary antibody LAMP1
(1:50, Santa Cruz Biotechnology, #sc19992) was used followed by incubation with
Alexa fluor 568-conjugated secondary antibodies (1:500, Molecular Probes).
Coverslips were rinsed in PBS, and directly mounted using Prolong Gold Antifade
reagent with DAPI (Life Technologies). Photographs were taken using a LSM
780 Confocal Inverted Microscope (Zeiss) at  40 or  63 magnification
(under immersion).
Collagen uptake experiment. A total of 1.5 105 PK4A cells were seeded on
12-well plates in duplicates and cultured 48 h in complete, glucose-deprived or
glutamine-deprived DMEM, with or without DQ-Fluorescein-conjugated collagen
IV or I (20 mgml 1, Life Technologies). Cysteine proteases inhibitor E64 (20 mM)
was added to each condition as described above. EIPA was used at 30 mM. 48 h
later, duplicates were pooled, cells washed in PBS and trypsinized (37 C), pelleted,
resuspended in bacterial collagenase (1mgml 1, 5min, room temperature (RT))
and quenched in Trypan Blue to eliminate external fluorescence (7min, RT), as
described in Ikenaga et al.33 and analysed by fluorescence-activated cell sorting
(FacsCalibur, BD Biosciences). Experiments were conducted in parallel in
normoxia (21%) and hypoxia (1% oxygen using a Whitley Hypoxic WorkStation,
Don Whitley Scientific).
Establishment of sg-PRODH1-PK4A cell lines. A total of 0.6 105 PK4A cells
were seeded on six-well plates 24 h before transfection with a pool of three PRODH
Crispr/Cas9 KO plasmids (Santa Cruz Biotechnologies, #sc-422425) each encoding
the Cas9 nuclease, a Green Fluorescent Protein (GFP) and a target-specific 20 nt
guide RNA (gRNA, sc-422425A1: sense: 50-TATCAGGTGCACCCCGCCTT-30 ,
sc-422425A2: sense: 50-AGTCTATCAGGCCTCTGATC-30 sc-422425A3: sense:
50-AGCCATTAAGCTCACTGCAC-30), using Lipofectamine 3000 (Life Technol-
ogies). 48 h post transfection, green fluorescent cells were cloned by cell sorting
using the fluorescence-activated cell sorting (ArialII, BD Biosciences). Clones were
then selected for maximal PRODH1 extinction.
Survival and proliferation assays. For survival assay, the experiments were
performed by culturing 1.2 105 PK4A cells in 24-well plates under 21% of oxygen
(normoxia) or 1% oxygen (hypoxia) either in complete medium (25mM glucose,
4mM glutamine DMEM) or in media with low glucose (0mM, 1mM or 5mM
glucose DMEM) or low glutamine (0mM or 0.5mM glutamine DMEM) alone or
supplemented with either DHP (1mM) or with DHP and L-proline (500 mM). Each
condition was repeated in quadruplicate. After 24 h, quadruplicates for each
condition were pooled, and viability assessed via Trypan blue exclusion using a cell
viability analyser (Vi-cell XR, Beckman Coulter). For proliferation assay, cells were
plated and cultured 24–96 h in same conditions as survival assay, except that media
were replenished every day. At each time point, cell viability was assessed via
Trypan blue exclusion using a cell viability analyser (Vi-cell XR, Beckman Coulter).
Survival assay under soluble collagen treatment were performed by culturing
4 106 PK4A cells on 10 cm petri dishes in no glucose DMEM with or without
water-soluble collagen IV (20 mgml 1), EIPA (30 mM) or both compounds. After
72 h, media were replaced by complete DMEM for 24 h. Cells were fixed and
stained with crystal violet (0.05% in methanol). Crystal violet was then dissolved in
acetic acid (10% in water), and staining quantified by spectrophotometry at
590 nm. For cell survival experiments using collagen I-coated, 5 105 PK4A cells
were cultured 96 h on collagen I-coated versus uncoated six-well plates, with no
glucose DMEM. Cells were further fixed and coloured with crystal violet (0.05% in
methanol) and representative photographs were taken.
Clonogenic assays. For clonogenic assays, 5 102 Sg-Control and Sg-
PRODH1_clone9 and _clone3 PK4a cells were seeded into a six-well plate and
cultured in complete media, 5 or 1mM glucose DMEM media. Ten days later,
colonies were fixed in 10% (wt/vol) formalin, stained with 0.5% Crystal violet,
imaged and quantified by ImageJ software (NIH).
PDAC syngeneic graft models. Under isoflurane anaesthesia (induction:
4% (vol/vol) and maintenance: 1.5% (vol/vol)), 5-week-old male Naval Medical
Research Institute (NMRI) nude mice (Envigo, France) were subcutaneously
implanted between the shoulders with 2 106 Sg-Control or Sg-PRODH1_clone 9
or _clone 3 PK4a cells. At the time of sacrifice (15 days post injection), tumours
were extracted from the mice and sizes were determined with calipers. Tumour
volume was established with the following formula: p/6 [(LþW)/2].
Nutrient uptake kinetics. Glucose and glutamine consumption or lactate
production were assessed using the YSI 2950 BioAnalyser (System-C-Industry).
Briefly, quadruplicates of subconfluent PK4A cells were cultured in 48-well plates
over 24 h either in 25mM glucose, 4mM glutamine DMEM, low glutamine
(2, 0.5mM), no glutamine or low glucose (5, 1mM), no glucose media. At each
end point, supernatants were collected and metabolite concentrations measured.
For glucose uptake and lactate production assessment under impairment of proline
degradation, 1.2 105 PK4A cells were seeded in quadruplicates in 24-well plates
in 0.5mM glutamine DMEM alone or supplemented with DHP (1mM), L-proline
(500 mM) or both compounds. After 24 h, supernatants were collected and glucose
and lactate concentrations measured as above. Viable cells numbers were evaluated
through Trypan blue exclusion test using a semi-automatic cell counter
(Countess, Life Technologies) and used for normalization. For every metabolite
measurements, fresh complete or nutrient-deprived media were used as starting
point for baseline concentrations.
Tracing experiments. For free proline tracing under normoxia, 1.5 105 PK4A
cells were plated in triplicate in six-well plates in complete medium. The following
day, cells were washed in PBS and refreshed with DMEM without pyruvate,
supplemented with 10% dialysed FBS and 500mM U-13C-proline for 24 h.
ECM with U-13C-proline was prepared according to methods adapted from
Vlodavsky et al.54. Briefly, primary MEFs were seeded at 75 103 cells/six-well on
fibronectin pre-coated plates (BD Biosciences) in DMEM (with pyruvate) with 10%
FBS. One day after plating, cells were switched into DMEM (with pyruvate) with
10% dialysed FBS supplemented with 500 mM U-13C-proline and 100mM Vitamin
C. Cells were cultured for 6 days in this media, with media renewal every 48 h.
After six days, MEFs were removed by washing in 1ml per well PBS with 0.5%
(v/v) Triton X-100 and 20mM NH4OH. Labelled ECM was washed four times with
PBS before plating 1.5 105 PK4A cells per well. The following day, PK4A cells
were switched into the indicated media (with 0.5% dialysed FBS) for 24 h. For free
proline tracing experiments in hypoxia, 1 105 cells were plated 6 h before
initiation of the experiment. At the start of the experiment, cells were washed once
with PBS and then switched into the indicated experimental media containing
500 mM U-13C-proline and placed for 24 h under normoxic (21% oxygen) or
hypoxic (1% oxygen) conditions. After 24 h, cells were harvested, extracted and
analysed as described below. For glucose tracings to lactate, 5 104 cells were
plated 1 day before initiation of the experiment. At the start of the experiment, cells
were washed once with PBS and then switched into the indicated experimental
media containing 25mM U-13C-glucose with 4mM, 2mM or 0.5mM glutamine.
At the indicated time points, cells were harvested, extracted and analysed as
described below. Tracing under DHP was similar apart from the following
exceptions: 1 105 cells were plated 6 h before initiation of the experiment. At the
start of the experiment, cells were washed once with PBS and then switched into
the indicated experimental media containing 500mM U-13C-proline±1mM DHP.
After 24 h, cells were harvested, extracted and analysed as described below. In
experiments where normalization to cell number was needed, a parallel plate
maintained under the same condition was used and tracing results were normalized
to raw cell counts (via microscopy) from those plates.
Extraction of metabolites. At the conclusion of tracing experiments, cells were
rinsed once in water and snap-frozen in liquid nitrogen and metabolites
were extracted with a methanol:chloroform:water (5:5:3) mix, as previously
described55,56. After vortexing and centrifugation to clarify, the aqueous phase
containing polar metabolites was removed, dried down under nitrogen gas and
stored at  80 C for subsequent derivatization. Acid hydrolysis was performed on
U-13C-proline labelled ECM to assess fractional incorporation of proline according
to the protocol adapted from Antoniewicz et al.57. Briefly, ECM was boiled in
500 ml 18% hydrochloric acid O/N at 100 C. Two-fifty microlitre supernatant was
evaporated under nitrogen and frozen at  80 C for subsequent derivatization. To
determine the relative abundance of amino acids in in vitro-generated ECM, we
adapted a previously described41 protocol. Briefly, the samples were boiled at
100 C overnight in 18% hydrochloric acid modified to include an amino acid
internal standard mixture of U-13C and U-15N species (Cambridge Isotopes,
# MSK-A2-1.2) at a final concentration of 100 mM. Samples were then run on the
gas chromatography-mass spectrometry as described in the following section. The
ratio of ion counts of unlabelled and fully labelled versions of each amino acid was
calculated. The fully labelled standards contain each amino acid at equal
concentrations, so these calculated ratios represent their relative abundances. We
therefore normalized the sum of these ratios to equal one to calculate the fraction
of protein amino acids represented by each individual amino acid. Cysteine and
tryptophan residues are acid labile and not recoverable from the hydrolyzed
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samples. Histidine was also not recovered from the samples. Fractionation using
trizol and determination of relative contributions were conducted as previously
described34. Unique to this experiment, cells were cultured for 72 h with daily
refreshing in indicated media conditions supplemented 500mM proline with tracer
of 0.05 mCiml 1 [U-14C]-proline.
Gas chromatography/mass spectrometry analyses. Dried polar metabolites
were dissolved in 20 ml of 2% methoxyamine hydrochloride in pyridine
(ThermoFischer Scientific) and held at 37 C for 1.5 h. After dissolution and
reaction, tert-butyl-di-methyl-silyl derivatization was initiated by adding 25 ml
N-methyl-N-(tert-butyl-di-methyl-silyl) trifluoroacetamideþ 1% tert-butyl-dime-
thyl-chlorosilane (Sigma-Aldrich) and incubating at 37 C for 1hr. For acid
hydrolysates, 20 ml pyridine (Sigma-Aldrich) was used in place of 2% methox-
yamine hydrochloride in pyridine. 25 ml N-methyl-N-(tert-butyl-di-methyl-silyl)
trifluoroacetamideþ 1% tert-butyl-dimethyl-chlorosilane and incubating at 37 C
for 1hr was performed as with polar metabolites. GC/MS analysis was performed
using an Agilent 7890 GC equipped with a 30m DB-35MS capillary column
connected to an Agilent 5975B MS operating under electron impact ionization at
70 eV. One microliter of sample was injected in splitless mode at 270 C, using
helium as the carrier gas at a flow rate of 1mlmin 1. For measurement of amino
acids, the GC oven temperature was held at 100 C for 3min and increased to
300 C at 3.5 Cmin 1. The MS source and quadrupole were held at 230 C and
150 C, respectively, and the detector was run in scanning mode, recording ion
abundance in the range of 100–605m/z. MIDs were determined by integrating the
appropriate ion fragments listed in supplementary Table 2 and corrected for
natural isotope abundance using an algorithm adapted from Fernandez and
colleagues58. MIDs are listed in Supplementary Data 1.
Mitochondrial oxygen consumption. Oxygen consumption rates were deter-
mined using a Seahorse XF24 extracellular flux analyser (Seahorse Bioscience,
Billerica, MA, USA). PK4A cells were seeded in XF24 V7 multi-well plates (30,000
cells per well). The next day, cells were treated with DHP (1mM) alone or
combined with L-Proline (0.5mM) for 24 h in media containing 0.5mM glutamine,
5mM or 1mM glucose. The day of measurements, culture media was replaced with
assay media (DMEM without phenol red, 143mM NaCl, 100mM sodium pyruvate
with 0.5mM glutamine, 5mM or 1mM glucose, pH7.4) and plates incubated at
37 C for 1hr before the start of measurement. OCR (oxygen consumption rate)
was measured before and after sequential injection of the following inhibitors:
oligomycin 1 mM, FCCP 1 mM and rotenone/antimycin 0.5 mM. OCR were
normalized to viable PK4A cells determined by Trypan blue exclusion test using a
semi-automatic cell counter (Countess, Life technologies).
Statistical analysis. Two-tailed unpaired Student’s t-test was used for comparing
means of two experimental groups in the case of one independent factor, except for
PDAC (n¼ 10) and normal pancreases (n¼ 11) PRODH1 levels comparison, we
used a Mann–Whitney non-parametric test since data do not follow a normal
distribution. Two-way analysis of variance, followed by the Bonferroni test for
multiple comparisons, was used when comparing more than two experimental
groups (Prism 6 software, version 6.01). In all figures, data are presented as
mean±s.e.m. and exact sample size (n), corresponding to biological replicates,
used to calculate the statistics are indicated. Po0.05 values were considered
statistically significant. No statistical methods were used to predetermine sample
size. Raw data are available in Supplementary Fig. 10a,b.
Data availability. The authors declare that the data supporting the findings of this
study are available within the paper and its Supplementary Information files or
from the corresponding author upon reasonable request.
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